The following grant opportunities do not require a letter of intent in the current grant cycle.

Award cycles for the ATS Research Program unrestricted, diversity, and partner grants have recently been updated to align with the calendar year. Please review the timeline below for further details.

Applicants to 2024-2025 partner grants will be notified of award decisions in March 2025.

• Unless stated otherwise, all grants are targeted towards early-career investigators. 
  • We strongly advise reviewing eligibility criteria, instructions and the descriptions below before starting an application.
  • You will be required to pass an eligibility quiz to gain access to the application. Be sure to check your eligibility before beginning the quiz as once submitted, your answers cannot be changed. 
• Links to the eligibility quiz and online application form can be found following each grant description below.
• Already started an application? Log in to continue where you left off.
• Questions? Review the FAQs
• Need help? Contact the ATS Research Program

Timeline

ATS/Alveolar Capillary Dysplasia (ACDMPV) Research Grant 

One grant available
$100,000 for one year

Target Audience: Investigators at any stage of their academic career interested in ACDMPV research.

This grant will support research in alveolar capillary dysplasia with misalignment of the pulmonary veins (ACDMPV). Proposals shall have a high likelihood of advancing the understanding of ACDMPV through basic, translational, or clinical research. Priority will be given to projects focused on the potential treatment of ACDMPV, rather than cause, early detection, or diagnosis. Procedures or proposed therapeutic trials may be new, based on recent biochemical or pharmacological evidence, or in preliminary stages of clinical investigation.

Applicants may request up to $100,000 for one year for salaries or supplies or a combination thereof.

Indirect costs will not be paid to the sponsoring institution.

Co-funded by the ACDA and The David Ashwell Foundation.

The ACDA and The David Ashwell Foundation are respectively USA- and UK-based not for profit charitable organizations founded by parents of infants with ACDMPV. Funds are raised by parents, families, and friends globally with the aim of increasing scientific knowledge about ACDMPV and therapeutic strategies related thereto.

Apply for the ATS/Alveolar Capillary Dysplasia (ACDMPV) Research Grant.

ATS/Alpha-1 Foundation Young Investigator Grant in Alpha-1 Antitrypsin Deficiency  

One grant available 
$50,000 for one year

Target Audience: Early-career investigators interested in Alpha-1 Antitrypsin Deficiency research. 

The objective of this grant is to provide support for early-career investigators who are starting their research careers and intend to pursue a career in Alpha-1 Antitrypsin Deficiency research.

Applications will be accepted from candidates holding an MD, PhD, or equivalent degree who are interested in conducting basic science, clinical research, or ethic, legal, or social issues studies related to AAT deficiency.

Applicants must indicate a commitment to AAT-related research by focusing 50% of their time on AAT deficiency research or clinical practice.

Indirect costs will not be paid to the sponsoring institution.

Funded by the Alpha-1 Foundation, Inc.  

Apply for the ATS/Alpha-1 Foundation Young Investigator Grant in Alpha-1 Antitrypsin Deficiency. 

ATS/Chiesi USA, Inc. Research Grant in Obstructive Lung Disease

One grant available
$50,000 for one year

Target Audience: Early-career investigators interested in obstructive lung disease research.

This grant will support research that has a high likelihood of advancing the understanding of obstructive lung disease through basic, translational, or clinical research.

Grant funds may be used to provide salary support for the PI or ancillary staff, to purchase supplies and/or reagents, or for subject enrollment fees directly related to the project or other allowable costs. Indirect costs will not be paid to the sponsoring institution.  

Fully funded by Chiesi USA, Inc.

Apply for the ATS/Chiesi USA, Inc Research Grant in Obstructive Lung Disease.

ATS Early-Career Investigator Award in Pulmonary Vascular Disease

Four grants available
$100,000 for one year

Target Audience: Early-career investigators conducting research on the basic mechanisms and/or vascular biology of pulmonary vascular disease. Applicants may be a junior faculty member up to and including the rank of assistant professor, a postdoctoral scholar, a doctoral candidate, or a fellow.

Note that the definition for early-career investigator for this award differs from that of other ATS awards. View complete eligibility requirements.

This grant supports basic, translational, and clinical research aimed at understanding the pathways and pathophysiology of pulmonary vascular disease, with the goal of improving treatment for patients with pulmonary hypertension.

Award-specific eligibility:

• Must be a US or Canadian citizen or permanent resident working at a US or Canadian institution
• Must have a firm commitment from their home institution for mentored career development
• Review the complete eligibility criteria for this award.

Funded by Johnson & Johnson. 

Apply for the ATS Early Career Investigator Award in Pulmonary Vascular Disease.